Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-25

FDA Approved: CARBOPROST TROMETHAMINE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves ANI Pharmaceuticals' original application for a generic carboprost tromethamine product, used to induce abortion and to treat postpartum hemorrhage…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPROST TROMETHAMINE (CARBOPROST TROMETHAMINE)

Snippet

ORIG AP for CARBOPROST TROMETHAMINE (CARBOPROST TROMETHAMINE)